Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Overall Study	STARTED	Placebo	104
Overall Study	STARTED	10 Milligram (mg) JZP385	105
Overall Study	STARTED	20 mg JZP385	104
Overall Study	STARTED	30 mg JZP385	107
Overall Study	COMPLETED	Placebo	91
Overall Study	COMPLETED	10 Milligram (mg) JZP385	78
Overall Study	COMPLETED	20 mg JZP385	81
Overall Study	COMPLETED	30 mg JZP385	78
Overall Study	NOT COMPLETED	Placebo	13
Overall Study	NOT COMPLETED	10 Milligram (mg) JZP385	27
Overall Study	NOT COMPLETED	20 mg JZP385	23
Overall Study	NOT COMPLETED	30 mg JZP385	29

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT05122650/flow